We are excited to share with you an insightful video interview with Professor Matt Dun from the University of Newcastle, Australia. In this interview, Professor Dun discusses the potential ground-breaking disruptive role of Kazia’s drug paxalisib in treating Diffuse Intrinsic Pontine Glioma (DIPG), an extremely aggressive form of childhood brain cancer.
